sarcoma
Cancer Risk Variants Found in Significant Subset of Sarcoma Patient Germlines
A retrospective analysis of multi-gene panel tests for more than 300 adult sarcoma patients unearthed pathogenic or likely pathogenic variants in cancer genes in 16 percent of cases.
Blood Testing Distinguishes Benign Tumors From Precancerous Condition
Researchers used ultra-low-pass whole genome sequencing and cell-free DNA fragment size selection to detect pre-cancer in neurofibromatosis type 1 patients.
Tool Detects Pediatric Bone Tumors From Liquid Biopsies Based on Epigenetic Profiles
Epigenetic signatures of Ewing sarcoma affect cell-free DNA fragmentation patterns and can be used to detect cancer.
With a new $16 million NCI grant, Count Me In is working with the Broad and Dana-Farber to engage osteosarcoma and leiomyosarcoma patients in their own care and in research.
Secondary Tumor Risk in Pediatric Cancer Survivors Linked to Germline Variants, Treatment Type
An analysis of pediatric cancer survivors suggests subsequent neoplasm risk can increase after certain genotoxic treatments in those with DNA repair gene changes.